Eastpro Technology Inc. ( China (Mainland))

Eastpro Technology Inc. is a pharmaceutical company specialized in the development and manufacture of pharmaceutical chemicals and nutritional supplements. At present, the company can offer a number of synthetic drugs, fermentation-derived medicines, biotech products, botanical extracts, pharmaceutical and chemical intermediates and nutritional supplements such as Ubidecarenone with cas registry number of 303-98-0, Benzylhydrazine with cas registry number of 555-96-4, 1,1-Dibenzylhydrazine with cas registry number of 5802-60-8, L-Prolinamide with cas registry number of 7531-52-4, Mupirocin with cas registry number of 12650-69-0. The major products include antibiotics, anti-diabetics and statins. All products are manufactured in China and exported to overseas markets.

Founded in 2000, the company is a 50/50 joint venture of Huadong Pharmaceutical Group of China and Pronet Science Inc. of US with principle business place at Hangzhou, China. Its management team has extensive global experience. It also has a capable R&D team. To meet global GMP standards and regulatory requirements, the company has established a team of international professionals to strengthen quality and regulatory infrastructures.

Eastpro is also able to timely develop new products needed by customers.